Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001013594-10-000110
Filing Date
2010-02-08
Accepted
2010-02-08 17:17:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 FEBRUARY 8, 2010 spectrum13g-020810.htm SC 13G 255340
  Complete submission text file 0001013594-10-000110.txt   257403
Mailing Address 157 TECHNOLOGY DR IRVINE CA 92618
Business Address 157 TECHNOLOGY DR IRVINE CA 92618 9497886700
SPECTRUM PHARMACEUTICALS INC (Subject) CIK: 0000831547 (see all company filings)

EIN.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-49329 | Film No.: 10581740
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVENUE 19TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVENUE 19TH FLOOR NEW YORK NY 10153 212-763-8000
Luxor Capital Group, LP (Filed by) CIK: 0001316580 (see all company filings)

EIN.: 201394199 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G